Read more about the study on psychotropic medications and Parkinson’s.
Antidepressants and anti-anxiety drugs may be linked to Parkinson’s disease risk in older women
Author: Scarlett SherriffPublished: 14 July 2022
Prep: Cook: Serves:
A recent study from scientists in the US and Saudi Arabia has revealed that the use of antidepressants and anxiety medications may be linked to the development of Parkinson’s in women aged 65 or over.
As part of their study, researchers examined data collected from 53,996 women included in the Women’s Health Initiative, a US health study which analysed morbidity and mortality in postmenopausal women between 1992 and 2005. Information regarding the use of medicine for depression and anxiety was available for 17,266 women. From the overall sample, 1,756 women developed Parkinson’s.
The team’s analysis found that use of antidepressants and anxiety medications correlated with an increased risk of Parkinson’s in older women.
Whilst the overall findings indicate a link between the medications and the onset of Parkinson’s, the study noted that it is possible that, “the underlying psychiatric disorders, namely depression/anxiety are the actual predisposing factors for Parkinson’s”.
For more information on the latest Parkinson’s research, please visit the EPDA website.
Share this story
Pill shows potential to help slow Parkinson’s disease progression
Researchers in Norway have shared findings on an oral supplement which mayREAD MORE
Can over-the-counter drugs reduce risk of developing genetic Parkinson’s?
A new study suggests that regular use of non-steroidal anti-inflammatory drREAD MORE
Ask the expert: Parkinson’s disease and mental health
Professor Dr Bernd Leplow on why communication about symptoms is crucialREAD MORE